A Study of QL1706 Combined With Chemotherapy in Advanced Non-small Cell Lung Cancer

Clinical trial NCT05329025 · UNKNOWN

Trial details

NCT number: NCT05329025
Sponsor: Qilu Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small-cell Lung Cancer

Start date: 2022-06-01
Primary completion: 2024-01-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.